Healthcare
Live Price
Offline$4.73
+3.05% today
1Y Change
-65.61%
Window
Jun 20, 2025 → Jun 16, 2026
Coverage: 248 bars · Jun 20, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
RxSight, Inc. (RXST) is a Healthcare stock with a market cap of $300.00M and listed on NASDAQ. The stock last traded around $4.73 and down 65.6% across the available one-year price window (Jun 20, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of -3.9%, EPS growth of -33.8%, a dividend yield of 0.0%. What stands out right now is revenue -3.9%, EPS -33.8%, free cash flow +13.6% with operating margin -35.8% and ROIC -16.8%. Valuation is more restrained than many high-expectation growth names at price/sales 2.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RXST price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RXST
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RXST Max Drawdown
-66.42%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RXST and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.